OBJECTIVE: There is evidence suggesting a strong genetic background of polycystic ovary syndrome (PCOS). We aim to study the metabolic and endocrine characteristics of PCOS women with and without a family history (FHx) of type 2 diabetes mellitus (T2DM) and PCOS. DESIGN: Cross-sectional study. METHODS: We analysed the association of T2DM FHx and PCOS FHx with metabolic and endocrine parameters in 714 PCOS women. RESULTS: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOS women respectively. We found an independent association of T2DM FHx with central fat accumulation, obesity, prediabetes, metabolic syndrome (MS), insulin resistance, low HDL and elevated blood pressure (P<0.05 for all). PCOS FHx was independently associated with prediabetes (P<0.05). We observed an independent association of PCOS FHx with clinical and biochemical hyperandrogenism (P<0.05 for all), whereas there was no independent association of T2DM FHx with hyperandrogenism. PCOS women with a positive FHx of both T2DM and PCOS had an adverse metabolic and endocrine profile including a linear increase in risk of obesity, central fat accumulation, MS, prediabetes and low HDL (P<0.05 for all). CONCLUSIONS: Our findings suggest that the assessment of FHx might allow risk stratification of PCOS women, which is important considering the high prevalence of PCOS.
OBJECTIVE: There is evidence suggesting a strong genetic background of polycystic ovary syndrome (PCOS). We aim to study the metabolic and endocrine characteristics of PCOSwomen with and without a family history (FHx) of type 2 diabetes mellitus (T2DM) and PCOS. DESIGN: Cross-sectional study. METHODS: We analysed the association of T2DM FHx and PCOSFHx with metabolic and endocrine parameters in 714 PCOSwomen. RESULTS: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOSwomen respectively. We found an independent association of T2DM FHx with central fat accumulation, obesity, prediabetes, metabolic syndrome (MS), insulin resistance, low HDL and elevated blood pressure (P<0.05 for all). PCOSFHx was independently associated with prediabetes (P<0.05). We observed an independent association of PCOSFHx with clinical and biochemical hyperandrogenism (P<0.05 for all), whereas there was no independent association of T2DM FHx with hyperandrogenism. PCOSwomen with a positive FHx of both T2DM and PCOS had an adverse metabolic and endocrine profile including a linear increase in risk of obesity, central fat accumulation, MS, prediabetes and low HDL (P<0.05 for all). CONCLUSIONS: Our findings suggest that the assessment of FHx might allow risk stratification of PCOSwomen, which is important considering the high prevalence of PCOS.
Authors: Havagiray R Chitme; Eman A K Al Azawi; Anfal M Al Abri; Buthina M Al Busaidi; Zamzam K A Salam; Maisa M Al Taie; Saja K Al Harbo Journal: J Taibah Univ Med Sci Date: 2017-01-13
Authors: David C Kem; Hongliang Li; Xichun Yu; Elizabeth Weedin; Anna C Reynolds; Elizabeth Forsythe; Marci Beel; Hayley Fischer; Brendon Hines; Yankai Guo; Jielin Deng; Jonathan T Liles; Zachary Nuss; Myriam Elkosseifi; Christopher E Aston; Heather R Burks; LaTasha B Craig Journal: J Endocr Soc Date: 2020-06-18